Valsartan Tablet
Product Images NDC 62332-044

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 62332-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valsartan 160mg

Label for Valsartan Tablets USP 160 mg, oral tablets in a 30-count package by Alembic Pharmaceuticals Inc. The label includes dosage information, storage instructions, manufacturer details in India and the USA, a barcode, and registration numbers.*

FDA Label Image

Valsartan 320mg

Label for Valsartan Tablets USP 320 mg oral tablets by Alembic Pharmaceuticals Inc. The label includes dosage information, storage instructions, and patient safety warnings. The package contains 30 film-coated tablets. Manufactured by Alembic Pharmaceuticals Limited in India and marketed by Alembic Pharmaceuticals, Inc., USA. Barcode and lot/expiration coding area are visible.*

FDA Label Image

Valsartan 40mg

Label for Valsartan Tablets USP 40 mg oral tablets, manufactured by Alembic Pharmaceuticals Inc. The label includes dosage and storage instructions, a barcode, and the package contains 30 tablets. The label also states 'Rx only' and provides manufacturer details in Gujarat, India and Bedminster, NJ, USA.*

FDA Label Image

Valsartan 80mg

Label for Valsartan Tablets USP 80 mg oral tablets manufactured by Alembic Pharmaceuticals Inc. The label includes storage instructions, dosage form, quantity of 30 tablets, NDC number 62332-045-30, and directions for pharmacists to dispense with a patient information sheet. It also includes barcode details and manufacturing locations in India and the USA.*

FDA Label Image

Valsartan Figur

A forest plot titled 'Effects on Mortality Amongst Subgroups in VALIANT' showing comparisons between Valsartan and Captopril across various patient subgroups including age, sex, race, region, and beta-blocker use. The horizontal axis ranges from 0.5 (Favors Valsartan) to 1.5 (Favors Captopril), with data points and confidence intervals for each subgroup indicating relative mortality effects.*

FDA Label Image

Structure (Valsartan Str)

Chemical structure diagram of the active ingredient Valsartan, showing its molecular connectivity and stereochemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.